- Home
- EDSA vs AWH Comparison
EDSA vs AWH Comparison
Compare EDSA & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- AWH
- Stock Information
- Founded
- EDSA 2015
- AWH 1993
- Country
- EDSA Canada
- AWH United States
- Employees
- EDSA N/A
- AWH N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- AWH Medical/Dental Instruments
- Sector
- EDSA Health Care
- AWH Health Care
- Exchange
- EDSA Nasdaq
- AWH Nasdaq
- Market Cap
- EDSA 6.2M
- AWH 6.2M
- IPO Year
- EDSA N/A
- AWH N/A
- Fundamental
- Price
- EDSA $2.43
- AWH $0.22
- Analyst Decision
- EDSA Strong Buy
- AWH Buy
- Analyst Count
- EDSA 1
- AWH 2
- Target Price
- EDSA $21.00
- AWH $4.40
- AVG Volume (30 Days)
- EDSA 5.9M
- AWH 306.0K
- Earning Date
- EDSA 02-14-2025
- AWH 03-27-2025
- Dividend Yield
- EDSA N/A
- AWH N/A
- EPS Growth
- EDSA N/A
- AWH N/A
- EPS
- EDSA N/A
- AWH N/A
- Revenue
- EDSA N/A
- AWH $8,963,000.00
- Revenue This Year
- EDSA N/A
- AWH $11.87
- Revenue Next Year
- EDSA N/A
- AWH $79.10
- P/E Ratio
- EDSA N/A
- AWH N/A
- Revenue Growth
- EDSA N/A
- AWH N/A
- 52 Week Low
- EDSA $1.55
- AWH $0.21
- 52 Week High
- EDSA $5.59
- AWH $4.43
- Technical
- Relative Strength Index (RSI)
- EDSA 56.54
- AWH 21.26
- Support Level
- EDSA $2.30
- AWH $0.21
- Resistance Level
- EDSA $4.49
- AWH $0.36
- Average True Range (ATR)
- EDSA 0.30
- AWH 0.06
- MACD
- EDSA 0.05
- AWH -0.00
- Stochastic Oscillator
- EDSA 22.56
- AWH 4.76
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.